| Announce Date | 11/11/2025 |
| EPS Normalized Actual | $1.32 (Miss by $-0.02) |
| EPS GAAP Actual | $1.32 (Miss by $-0.02) |
| Revenue Actual | $2.417B |
| Revenue Surprise | Beat by $2417M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 2.29 | 46.79 | 1.89134 | 2.54186 | 1 |
| Dec 2029 | 4.95 | 21.65 | 4.56101 | 5.19781 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 1.32 | 1.32 | 2.417B | 38.31% | 2417M |
| FQ2 2025 (Jun 2025) | 1.33 | 1.33 | 2.445B | -4.38% | 2445M |
| FQ1 2025 (Mar 2025) | 0.88 | 0.88 | 1.963B | 35% | 1963M |
| FQ4 2024 (Dec 2024) | 1.03 | 1.03 | 1.75B | 100% | 1750M |
| FQ3 2024 (Sep 2024) | 0.53 | 0.53 | 1.491B | 100% | 1491M |
| FQ1 2024 (Mar 2024) | 0.37 | 0.37 | 1.276B | 100% | 1276M |
| FQ2 2024 (Jun 2024) | 0.74 | 0.74 | 2.552B | 100% | 2552M |
| FQ1 2016 (Mar 2016) | 0.0634 | 0.0634 | 0.98B | 100% | 980M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2028 (Nov 2028) | 2.0506 | -- | 2.0506 | 2.0506 | 1 |
| FQ3 2028 (Aug 2028) | 2.1846 | -- | 2.1846 | 2.1846 | 1 |
| FQ2 2028 (May 2028) | 2.1315 | -- | 2.1315 | 2.1315 | 1 |
| FQ1 2028 (Feb 2028) | 2.3766 | -- | 2.3766 | 2.3766 | 1 |
| FQ4 2027 (Nov 2027) | 1.70953 | -- | 1.70953 | 1.70953 | 1 |
| FQ3 2027 (Aug 2027) | 1.68913 | -- | 1.68913 | 1.68913 | 1 |
| FQ2 2027 (May 2027) | 1.59417 | -- | 1.59417 | 1.59417 | 1 |
| FQ1 2027 (Feb 2027) | 1.55327 | -- | 1.55327 | 1.55327 | 1 |
| FQ4 2026 (Nov 2026) | 1.74123 | -- | 1.74123 | 1.74123 | 1 |
| FQ3 2026 (Aug 2026) | 1.37 | 3.65 | 1.37 | 1.37 | 2 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2028 (Nov 2028) | 2.91B | -- | 2.91B | 2.91B | 1 |
| FQ3 2028 (Aug 2028) | 3B | -- | 3B | 3B | 1 |
| FQ2 2028 (May 2028) | 2.89B | -- | 2.89B | 2.89B | 1 |
| FQ1 2028 (Feb 2028) | 3.1B | -- | 3.1B | 3.1B | 1 |
| FQ4 2027 (Nov 2027) | 2.6B | -- | 2.6B | 2.6B | 1 |
| FQ3 2027 (Aug 2027) | 2.61B | -- | 2.61B | 2.61B | 1 |
| FQ2 2027 (May 2027) | 2.56B | -- | 2.56B | 2.56B | 1 |
| FQ1 2027 (Feb 2027) | 2.54B | -- | 2.54B | 2.54B | 1 |
| FQ4 2026 (Nov 2026) | 2.84B | -- | 2.84B | 2.84B | 1 |
| FQ3 2026 (Aug 2026) | 2.53B | 4.57 | 2.53B | 2.53B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 1.32 | 1.32 | 100% | |
| FQ2 2025 (Jun 2025) | 1.33 | 1.33 | 100% | |
| FQ1 2025 (Mar 2025) | 0.88 | 0.88 | 100% | |
| FQ4 2024 (Dec 2024) | 1.03 | 1.03 | 100% | |
| FQ3 2024 (Sep 2024) | 0.53 | 0.53 | 100% | |
| FQ1 2024 (Mar 2024) | 0.37 | 0.37 | 100% | |
| FQ2 2024 (Jun 2024) | 0.74 | 0.74 | 100% | |
| FQ1 2016 (Mar 2016) | 0.0634 | 0.0634 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0B | $2.42B | $2417M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $2.45B | $2445M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $1.96B | $1963M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $1.75B | $1750M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $1.49B | $1491M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $1.28B | $1276M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $2.55B | $2552M | 100% |
| FQ1 2016 (Mar 2016) | $0B | $0.98B | $980M | 100% |